Viewing Study NCT00908167


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2026-01-01 @ 1:15 PM
Study NCT ID: NCT00908167
Status: COMPLETED
Last Update Posted: 2018-01-12
First Post: 2009-05-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies
Sponsor: St. Jude Children's Research Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module